申请人:EDISON PHARMACEUTICALS, INC.
公开号:US20160039775A1
公开(公告)日:2016-02-11
Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
本文披露了一种resorufin衍生物化合物及其使用方法,用于治疗或抑制氧化应激性疾病,包括线粒体疾病、能量处理障碍、神经退行性疾病和衰老疾病。